Development and validation of a nomogram predicting presence of PSMA-negative but FDG-positive lesion in patients with castration-resistant prostate cancer: A multicentre, retrospective study

J. Pan; D.W. Ye; Y. Zhu

doi:10.1016/S2666-1683(22)02517-4

Abstract| Volume 45, SUPPLEMENT 2, S144, November 2022

Development and validation of a nomogram predicting presence of PSMA-negative but FDG-positive lesion in patients with castration-resistant prostate cancer: A multicentre, retrospective study

Pan J.
J. Pan
Search for articles by this author
Ye D.W.
D.W. Ye
Search for articles by this author
Zhu Y.
Y. Zhu
Search for articles by this author

Open AccessDOI:https://doi.org/10.1016/S2666-1683(22)02517-4

This paper is only available as a PDF. To read, Please Download here.

Article info

Identification

DOI: https://doi.org/10.1016/S2666-1683(22)02517-4

Copyright

User license

Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) |

How you can reuse Information Icon

ScienceDirect

Access this article on ScienceDirect

Toggle Thumbstrip

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Latest

Popular Articles

Prostate Cancer IRE Study (PRIS): A Randomized Controlled Trial Comparing Focal Therapy to Radical Treatment in Localized Prostate Cancer

C10 Beneficial effects of cranberries on prostate health: Evidence from a randomized controlled trial

PSA Levels and the Probability of Prostate Cancer on Biopsy

Latest Articles

Prior Robotic Console Expertise May Improve Basic Skills at the New Hugo RAS Simulator: Results from a Cohort Trial and Implications for Skill Transference Across Platforms

A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate Biopsy

Urodrill - a novel MRI-guided endoscopic biopsy technique to sample and molecularly classify muscle-invasive bladder cancer without fractionating the specimen during transurethral resection

For Authors

Society

Journal Information

Companion Journals

Contact

Follow Us

Development and validation of a nomogram predicting presence of PSMA-negative but FDG-positive lesion in patients with castration-resistant prostate cancer: A multicentre, retrospective study

Article info

Identification

Copyright

User license

ScienceDirect

Related Articles

Popular Articles

Prostate Cancer IRE Study (PRIS): A Randomized Controlled Trial Comparing Focal Therapy to Radical Treatment in Localized Prostate Cancer

C10 Beneficial effects of cranberries on prostate health: Evidence from a randomized controlled trial

PSA Levels and the Probability of Prostate Cancer on Biopsy

Latest Articles

Prior Robotic Console Expertise May Improve Basic Skills at the New Hugo RAS Simulator: Results from a Cohort Trial and Implications for Skill Transference Across Platforms

A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate Biopsy

Urodrill - a novel MRI-guided endoscopic biopsy technique to sample and molecularly classify muscle-invasive bladder cancer without fractionating the specimen during transurethral resection

Development and validation of a nomogram predicting presence of PSMA-negative but FDG-positive lesion in patients with castration-resistant prostate cancer: A multicentre, retrospective study

Article info

Identification

Copyright

User license

Permitted

For non-commercial purposes:

Not Permitted

ScienceDirect

Related Articles